Cargando…
Cardiac stem cells: A promising treatment option for heart failure
Cardiovascular diseases are the most common cause of death in the world. The development of heart failure is mainly due to the loss of cardiomyocytes following myocardial infarction and the absence of endogenous myocardial repair. Numerous studies have focused on cardiac stem cells (CSCs) due to the...
Autores principales: | ZHAO, XIAOHUI, HUANG, LAN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570189/ https://www.ncbi.nlm.nih.gov/pubmed/23407679 http://dx.doi.org/10.3892/etm.2012.854 |
Ejemplares similares
-
Cardiac stem cells in patients with heart disease
por: ZHAO, XIAOHUI, et al.
Publicado: (2013) -
Endogenous cardiac stem cells for the treatment of heart failure
por: Fuentes, Tania, et al.
Publicado: (2013) -
Stemming heart failure with cardiac- or reprogrammed-stem cells
por: Tateishi, Kento, et al.
Publicado: (2008) -
Soluble Guanylyl Cyclase Activators—Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension
por: Grześk, Grzegorz, et al.
Publicado: (2023) -
Cardiac Myosin Activation in the Treatment of Congestive Heart Failure: New Therapeutic Options and Review of Literature
por: Ali, Arroj, et al.
Publicado: (2021)